Observational studyBMC ophthalmology2026
Correlation between mid-term intraocular pressure and aqueous flare value in micropulse transscleral cyclophotocoagulation: a retrospective observational study.
Observational study in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMicropulse transscleral cyclophotocoagulation (MP-TSCPC) lowers intraocular pressure (IOP), but the mechanisms underlying its IOP-reducing effect remain incompletely understood. Although early postoperative flare elevation has been reported in association with IOP reduction, the relationship during the mid-term postoperative period has not been well characterized. In this study, the mid-term period was defined a priori as 3–18 months after surgery.
methodsThis retrospective exploratory study included 25 eyes of 25 patients who underwent initial MP-TSCPC at Ishida Eye Clinic between March 2019 and May 2022 and had available postoperative flare measurements. Aqueous flare was assessed using a laser flare meter, and IOP was measured primarily by Goldmann applanation tonometry. Flare increase ratio (%) and IOP reduction ratio (%) were calculated relative to baseline. Associations were evaluated using Spearman’s rank correlation coefficient. To account for multiple comparisons across postoperative time points, p-values were adjusted using the Benjamini–Hochberg procedure, primarily considering a false discovery rate (FDR) threshold of 0.05; findings at FDR < 0.10 were interpreted as exploratory.
resultsThe mean age was 80.4 ± 10.3 years. The mean preoperative IOP was 17.6 ± 6.9 mmHg, and the mean preoperative flare value was 13.9 ± 7.7 photon counts/ms. Postoperative IOP showed significant reductions at 1 and 12 months, and flare values were significantly elevated at multiple time points through 24 months. Significant positive correlations between flare increase ratio and IOP reduction ratio were observed at 3 months (ρ = 0.54, p = 0.026), 18 months (ρ = 0.964, p = 0.0027), and at the final visit (ρ = 0.41, p = 0.022). After adjustment for multiple comparisons, only the 18-month correlation remained significant at FDR < 0.05 (q = 0.022), whereas the correlations at 3 months (q = 0.069) and at the final visit (q = 0.088) were significant at FDR < 0.10 and were therefore considered exploratory.
conclusionsIn this small exploratory cohort, sustained postoperative aqueous flare elevation was associated with greater mid-term IOP reduction after MP-TSCPC. However, given the limited sample size and observational design, these findings should be interpreted cautiously, and causal mechanisms cannot be established.
trial registrationApproval Number: R2025063 (University of Toyama Ethics Committee). Registration date: July 10, 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.